quinazolines has been researched along with Dysplastic Nevus Syndrome, Hereditary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bobera, J; Dupuy, AJ; Feddersen, CR; Jennings, BM; Mullen, SA; Riordan, JD; Schillo, JL; Stipp, CS; Varzavand, A; Vaughn, HR; Voigt, AP; Wadsworth, LS; Zhu, EY | 1 |
| Chen, X; Guo, J; Liang, L; Liu, H; Liu, J; Liu, N; Peng, C; Qi, M; Su, J; Zhang, J; Zhao, S | 1 |
| Adamus, G; Amundson, D; Boon, CJ; Haanen, JB; Jager, MJ; Kapiteijn, EH; Keunen, JE; Luyten, GP; Marinkovic, M; van Dijk, EH; van Herpen, CM | 1 |
1 trial(s) available for quinazolines and Dysplastic Nevus Syndrome, Hereditary
| Article | Year |
|---|---|
Serous Retinopathy Associated with Mitogen-Activated Protein Kinase Kinase Inhibition (Binimetinib) for Metastatic Cutaneous and Uveal Melanoma.
Topics: Adult; Aged; Autoantibodies; Benzimidazoles; Central Serous Chorioretinopathy; Cross-Sectional Studies; Drug Combinations; Electrooculography; Electroretinography; Eye Proteins; Female; Fluorescein Angiography; Humans; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Mitogen-Activated Protein Kinase Kinases; Prospective Studies; Protein Kinase C; Pyrroles; Quinazolines; Skin Neoplasms; Subretinal Fluid; Tomography, Optical Coherence; Uveal Neoplasms; Visual Acuity | 2015 |
2 other study(ies) available for quinazolines and Dysplastic Nevus Syndrome, Hereditary
| Article | Year |
|---|---|
Src-Dependent DBL Family Members Drive Resistance to Vemurafenib in Human Melanoma.
Topics: Antineoplastic Agents; Benzodioxoles; Drug Resistance, Neoplasm; Guanine Nucleotide Exchange Factors; Humans; Melanoma; Melanoma, Cutaneous Malignant; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-vav; Quinazolines; Signal Transduction; Skin Neoplasms; src-Family Kinases; Vemurafenib | 2019 |
Potent USP10/13 antagonist spautin-1 suppresses melanoma growth via ROS-mediated DNA damage and exhibits synergy with cisplatin.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzylamines; Cell Line, Tumor; Cisplatin; DNA Damage; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Melanoma, Cutaneous Malignant; Mice; Quinazolines; Reactive Oxygen Species; Skin Neoplasms; Ubiquitin Thiolesterase; Ubiquitin-Specific Proteases; Xenograft Model Antitumor Assays | 2020 |